Skip to main content
main-content

medwireNews@EAN2020

medwireNews@EAN2020

27-05-2020 | Multiple sclerosis | Video

EAN 2020 | NfL chains predict visual recovery and neuroaxonal loss after acute optic neuritis

Gloria Dalla Costa reports study findings demonstrating the prognostic value of serum neurofilament light chains in acute optic neuritis (8:04).

27-05-2020 | Multiple sclerosis | Video

EAN 2020 | Ongoing reporting supports long-term safety of ocrelizumab in MS

Stephen Hauser reports the ongoing safety data for ocrelizumab in patients with relapsing or primary progressive multiple sclerosis, including preliminary post-marketing experience of a small group of patients with COVID-19 (5:13).

27-05-2020 | Multiple sclerosis | Video

EAN 2020 | Clinical activity predicts interferon-β treatment response in paediatric MS

Ermelinda De Meo outlines research showing clinical activity and ongoing magnetic resonance imaging activity in the first year indicates significant long-term risk of interferon-β treatment failure in paediatric patients with multiple sclerosis (4:36).

27-05-2020 | Multiple sclerosis | Video

EAN 2020 | Eculizumab reduces relapse in aquaporin-4 immunoglobulin G-positive NMOSD

Celia Oreja-Guevara presents phase 3 PREVENT study findings showing a reduction in relapse rates and relapse-related hospitalization for patients with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder receiving eculizumab (5:52).

26-05-2020 | Multiple sclerosis | Video

EAN 2020 | Artificial intelligence improves differential diagnosis in diseases mimicking MS

Laura Cacciaguerra highlights the benefits of a deep-learning algorithm applied to magnetic resonance images in the differential diagnosis of neuromyelitis optica spectrum disorder (6:31).

26-05-2020 | Multiple sclerosis | Video

EAN 2020 | Teriflunomide shows benefits in children with relapsing forms of MS

Tanuja Chitnis tells us about the TERIKIDS study showing a numerical reduction in clinical relapse risk and a significant reduction in time to clinical relapse with teriflunomide  in paediatric patients with relapsing-remitting multiple sclerosis (5:29).

25-05-2020 | Neurodegeneration | Video

EAN 2020 | Resource gaps identified ahead of intrathecal Huntington’s disease treatments

Jean-Marc Burgunder outlines the need for adequate planning by capacity-constrained healthcare systems to ensure the delivery of upcoming intrathecally administered disease-modifying therapies in patients with Huntington’s disease (6:04).

25-05-2020 | Multiple sclerosis | Video

EAN 2020 | Ocrelizumab benefits in MS extend to patients with previous treatment failure

Bianca Weinstock-Guttman presents the 2-year CHORDS study findings showing good outcomes among patients with relapsing-remitting multiple sclerosis receiving ocrelizumab after a suboptimal response to previous disease-modifying therapy (3:17).

25-05-2020 | Multiple sclerosis | Video

EAN 2020 | Clinical data support benefits of relapse prevention on QoL in NMOSD patients

Michael Levy discusses findings from the SAkura studies confirming a strong and consistent relationship between disability and quality of life in patients with neuromyelitis optica spectrum disorder (2:25).

24-05-2020 | Parkinson's disease | Video

EAN 2020 | Impulsivity underestimated in Parkinson’s disease

Angelo Antonini presents real-world data from the PRISM study, highlighting the prevalence of impulse control disorders in patients with Parkinson’s disease and their association with dopamine agonists (5:34).